ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,097Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 1006

$722K Total Retail Price of All Prescriptions

Rank: 99 out of 1006

396 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 396 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 396 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,517 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 462 440 1 4
LEVOTHYROXINE SODIUM 423 382 2 2
ATORVASTATIN CALCIUM 368 319 3 5
LISINOPRIL 338 262 4 3
SIMVASTATIN 297 258 5 1
FUROSEMIDE 270 245 6 6
METFORMIN HCL 257 189 7 10
HYDROCHLOROTHIAZIDE 240 230 8 11
METOPROLOL TARTRATE 228 228 9 7
WARFARIN SODIUM 188 176 10 8
CITALOPRAM HBR 186 160 11 24
PRAVASTATIN SODIUM 173 147 12 15
CRESTOR 166 134 13 18
ATENOLOL 162 152 14 13
ALENDRONATE SODIUM 160 145 15 29
ZOLPIDEM TARTRATE 149 64 16 14
OMEPRAZOLE 126 113 17 9
METOPROLOL SUCCINATE 123 100 18 12
NEXIUM 104 74 19 28
ATELVIA 99 99 20 182
RAMIPRIL 97 95 21 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 85 22 38
HYDROCODONE-ACETAMINOPHEN 95 60 S3 22 25
CLOPIDOGREL 87 87 24 46
MELOXICAM 87 81 24 67
DONEPEZIL HCL 85 83 26 17
LIPITOR 84 75 27 47
PANTOPRAZOLE SODIUM 81 81 28 32
NAMENDA 80 79 29 34
MIRTAZAPINE 79 79 30 26
PLAVIX 78 76 31 61
ESCITALOPRAM OXALATE 78 70 31 27
TAMSULOSIN HCL 74 74 33 23
ADVAIR DISKUS 73 63 34 37
CARVEDILOL 71 66 35 36
ISOSORBIDE MONONITRATE ER 68 68 36 59
FENOFIBRATE 66 48 37 109
SINGULAIR 65 54 38 82
BISOPROLOL-HYDROCHLOROTHIAZIDE 61 45 39 202
POTASSIUM CHLORIDE 59 50 40 30
SERTRALINE HCL 59 53 40 19
TRICOR 59 55 40 101
OXYCODONE-ACETAMINOPHEN 58 33 S2 43 57
AZOR 58 44 43 198
CELEBREX 56 33 45 90
BENAZEPRIL HCL 56 48 45 112
GABAPENTIN 55 23 47 20
LANSOPRAZOLE 55 55 47 141
SPIRIVA 52 49 49 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.